IFN-γ not only induces cell cycle arrest [19–22] but also enhances class I major histocompatibility complex (MHC-I) expression on the surface of tumor cells, a phenomenon that can promote immune surveillance by triggering CD8+ T cell recognition [23]. This evidence concerns the gene CD8A and neoplasm.